VIDAS TOTAL PSA

FDA Premarket Approval P040008 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for updating the packaging insert by defining the phrase "instrument of the vidas family" as "instrument of the vidas family: vidas or minividas"and replacing "instruments of the vidas family" with "vidas instruments" in the intended use. The device, vidas® total psa, is intended for use with the vidas instruments (vitek® immunodiagnostic assay system) as an automated enzyme-linked fluorescent immunoassay (elfa) for the quantitative measurement oftotal prostate specific antigen in human serum. The vidas tpsa assay is indicated as an aid in the management of patients with prostate cancer and as an aid in the detection of prostate cancer in conjunction with digital rectal examination (ore) in men age 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The device, vidas® free psa rt, is an automated quantitative test for use on the vidas instruments, for the quantitative measurement of the free fraction of prostate specific antigen (psa) in human serum using the elf a technique (enzyme linked fluorescent assay). The vidas free psa rt is intended to be used in conjunction with the vidas tpsa assay in men age 50 years or older who have digital rectal examination (ore) that is not suspicious for prostate cancer and vidas tpsa values between 4 and 10 ng/ml to determine the % free psa value. The vidas % free psa value can be used as an aid in discriminating between prostate cancer and benign disease. Prostate biopsy is required for diagnosis of prostate cancer.

DeviceVIDAS TOTAL PSA
Generic NameTotal, Prostate Specific Antigen (noncomplexed & Complexed) For Detection Of Prostate Cancer
ApplicantBioMerieux, Inc.
Date Received2012-10-11
Decision Date2013-01-18
PMAP040008
SupplementS003
Product CodeMTF 
Advisory CommitteeImmunology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address bioMerieux, Inc. 595 Anglum Rd. hazelwood, MO 63042

Supplemental Filings

Supplement NumberDateSupplement Type
P040008Original Filing
S013 2016-05-03 30-day Notice
S012 2015-07-06 30-day Notice
S011 2015-03-18 30-day Notice
S010
S009
S008 2014-02-03 30-day Notice
S007 2013-08-15 30-day Notice
S006 2013-02-12 30-day Notice
S005 2013-02-06 30-day Notice
S004 2012-12-18 30-day Notice
S003 2012-10-11 Real-time Process
S002 2012-01-09 30-day Notice
S001 2008-09-04 30-day Notice

NIH GUDID Devices

Device IDPMASupp
03573026156985 P040008 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.